Actively Recruiting
Clariance Registry to Track Safety and Outcomes of ERISMA and Idys Spine Implants in Adults
Led by Clariance · Updated on 2026-03-17
760
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are conducting an international, prospective, single-arm, multicenter observational study called the Clariance ErYs Registry. This study focuses on evaluating the safety and performance of various spine implant devices in real-world settings. It aims to collect data on complications and functional outcomes related to spine degeneration, spondylosis, deformity, tumors, and fractures. The primary goal is to assess the safety of these devices, while a secondary goal is to evaluate their impact on pain, quality of life, and daily activities. Participants will receive implantation of spine Interbody Fusion Devices andor Posterior Fixation Systems using different types of ERISMA and Idys implants. The study tracks clinical outcomes over multiple time points preoperative, 9 weeks, 6 months, 1 year, and 2 years after surgery. The implants include various models such as ERISMA LPLP EVO, Deformity, MIS, and Idys devices like TLIF and ALIF with different materials and designs. During the study, participants will undergo evaluations including pain assessment using Visual Analog Score, disability measurement with Oswestry Disability Index, quality of life surveys SF-12v2, satisfaction ratings, radiological checks for bone fusion, and monitoring for adverse events or device deficiencies. The research team will review revision rates at two years as the primary outcome. Participant involvement spans about two years with multiple follow-up visits to collect comprehensive safety and performance data.
CONDITIONS
Brief Title
Clariance ErYs Registry
Research Team
F
Florian Laboulfie
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here